Everolimus for the treatment of advanced pancreatic neuroendocrine tumors: Overall survival and circulating biomarkers from the randomized, Phase III RADIANT-3 study

James C. Yao, Marianne Pavel, Catherine Lombard-Bohas, Eric Van Cutsem, Maurizio Voi, Ulrike Brandt, Wei He, David Chen, Jaume Capdevila, Elisabeth G.E. De Vries, Paola Tomassetti, Timothy Hobday, Rodney Pommier, Kjell Öberg

    Research output: Contribution to journalArticlepeer-review

    126 Scopus citations

    Fingerprint

    Dive into the research topics of 'Everolimus for the treatment of advanced pancreatic neuroendocrine tumors: Overall survival and circulating biomarkers from the randomized, Phase III RADIANT-3 study'. Together they form a unique fingerprint.

    Medicine & Life Sciences